Clinical Significance of Early Repolarization in Long QT Syndrome

Alan Sugrue, Ram K. Rohatgi, Martijn Bos, Vaibhav R. Vaidya, Samuel J Asirvatham, Peter Noseworthy, Michael John Ackerman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: This study sought to determine the prevalence of early repolarization pattern (ERP) within a large cohort of patients with long QT syndrome (LQTS) and examine the correlation and clinical significance of ERP with symptomatic status and subsequent risk of breakthrough cardiac events (BCEs). Background: The electrocardiographic ERP is associated with an increased risk of arrhythmic events and sudden cardiac death. Methods: ERP was defined as an end-QRS notch or slur on the downslope of a prominent R-wave with a J point ≥0.1 mV in 2 or more contiguous leads of the 12-lead electrocardiogram, excluding V1 to V3. A patient was considered previously symptomatic if they had a suspected LQTS-triggered cardiac event prior to diagnosis. BCEs were defined as LQTS-attributable syncope/seizures, aborted cardiac arrest, appropriate ventricular fibrillation–terminating implantable cardioverter-defibrillator shocks, and sudden cardiac death following diagnosis and institution of a LQTS-directed treatment program. Results: In this study, 528 patients (57% female) with genotype-confirmed LQTS (283 with LQT1, 193 with LQT2, and 52 with LQT3) were reviewed from which 2,618 electrocardiograms were analyzed over a median follow-up of 6.7 (interquartile range, 3.6 to 10 years) years. Eighty-two (15.5%; female 51%) patients were identified as having ERP; 40 (50%) of these ERP-positive patients showed persistent ERP. One hundred twenty-four patients (23.5%) were classified as previously symptomatic LQTS and 39 (7.2%) experienced a subsequent BCE. ERP was not associated with either symptomatic status (p = 0.62) or BCE (p = 0.61). Conclusions: Although ERP is common in LQTS, this extensive study suggests that the presence of concomitant ERP does not correlate with either those with a history of LQTS-triggered events prior to diagnosis or those with subsequent BCEs from their treated LQTS substrate.

Original languageEnglish (US)
Pages (from-to)1238-1244
Number of pages7
JournalJACC: Clinical Electrophysiology
Volume4
Issue number9
DOIs
StatePublished - Sep 1 2018

Fingerprint

Long QT Syndrome
Sudden Cardiac Death
Electrocardiography
Implantable Defibrillators
Syncope
Heart Arrest
Shock
Seizures
Genotype

Keywords

  • breakthrough cardiac events
  • early repolarization
  • electrophysiology
  • long QT syndrome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Clinical Significance of Early Repolarization in Long QT Syndrome. / Sugrue, Alan; Rohatgi, Ram K.; Bos, Martijn; Vaidya, Vaibhav R.; Asirvatham, Samuel J; Noseworthy, Peter; Ackerman, Michael John.

In: JACC: Clinical Electrophysiology, Vol. 4, No. 9, 01.09.2018, p. 1238-1244.

Research output: Contribution to journalArticle

Sugrue, Alan ; Rohatgi, Ram K. ; Bos, Martijn ; Vaidya, Vaibhav R. ; Asirvatham, Samuel J ; Noseworthy, Peter ; Ackerman, Michael John. / Clinical Significance of Early Repolarization in Long QT Syndrome. In: JACC: Clinical Electrophysiology. 2018 ; Vol. 4, No. 9. pp. 1238-1244.
@article{8c08e2c8b5c74a3a93f1f1c367fc67de,
title = "Clinical Significance of Early Repolarization in Long QT Syndrome",
abstract = "Objectives: This study sought to determine the prevalence of early repolarization pattern (ERP) within a large cohort of patients with long QT syndrome (LQTS) and examine the correlation and clinical significance of ERP with symptomatic status and subsequent risk of breakthrough cardiac events (BCEs). Background: The electrocardiographic ERP is associated with an increased risk of arrhythmic events and sudden cardiac death. Methods: ERP was defined as an end-QRS notch or slur on the downslope of a prominent R-wave with a J point ≥0.1 mV in 2 or more contiguous leads of the 12-lead electrocardiogram, excluding V1 to V3. A patient was considered previously symptomatic if they had a suspected LQTS-triggered cardiac event prior to diagnosis. BCEs were defined as LQTS-attributable syncope/seizures, aborted cardiac arrest, appropriate ventricular fibrillation–terminating implantable cardioverter-defibrillator shocks, and sudden cardiac death following diagnosis and institution of a LQTS-directed treatment program. Results: In this study, 528 patients (57{\%} female) with genotype-confirmed LQTS (283 with LQT1, 193 with LQT2, and 52 with LQT3) were reviewed from which 2,618 electrocardiograms were analyzed over a median follow-up of 6.7 (interquartile range, 3.6 to 10 years) years. Eighty-two (15.5{\%}; female 51{\%}) patients were identified as having ERP; 40 (50{\%}) of these ERP-positive patients showed persistent ERP. One hundred twenty-four patients (23.5{\%}) were classified as previously symptomatic LQTS and 39 (7.2{\%}) experienced a subsequent BCE. ERP was not associated with either symptomatic status (p = 0.62) or BCE (p = 0.61). Conclusions: Although ERP is common in LQTS, this extensive study suggests that the presence of concomitant ERP does not correlate with either those with a history of LQTS-triggered events prior to diagnosis or those with subsequent BCEs from their treated LQTS substrate.",
keywords = "breakthrough cardiac events, early repolarization, electrophysiology, long QT syndrome",
author = "Alan Sugrue and Rohatgi, {Ram K.} and Martijn Bos and Vaidya, {Vaibhav R.} and Asirvatham, {Samuel J} and Peter Noseworthy and Ackerman, {Michael John}",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/j.jacep.2018.06.007",
language = "English (US)",
volume = "4",
pages = "1238--1244",
journal = "JACC: Clinical Electrophysiology",
issn = "2405-5018",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - Clinical Significance of Early Repolarization in Long QT Syndrome

AU - Sugrue, Alan

AU - Rohatgi, Ram K.

AU - Bos, Martijn

AU - Vaidya, Vaibhav R.

AU - Asirvatham, Samuel J

AU - Noseworthy, Peter

AU - Ackerman, Michael John

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Objectives: This study sought to determine the prevalence of early repolarization pattern (ERP) within a large cohort of patients with long QT syndrome (LQTS) and examine the correlation and clinical significance of ERP with symptomatic status and subsequent risk of breakthrough cardiac events (BCEs). Background: The electrocardiographic ERP is associated with an increased risk of arrhythmic events and sudden cardiac death. Methods: ERP was defined as an end-QRS notch or slur on the downslope of a prominent R-wave with a J point ≥0.1 mV in 2 or more contiguous leads of the 12-lead electrocardiogram, excluding V1 to V3. A patient was considered previously symptomatic if they had a suspected LQTS-triggered cardiac event prior to diagnosis. BCEs were defined as LQTS-attributable syncope/seizures, aborted cardiac arrest, appropriate ventricular fibrillation–terminating implantable cardioverter-defibrillator shocks, and sudden cardiac death following diagnosis and institution of a LQTS-directed treatment program. Results: In this study, 528 patients (57% female) with genotype-confirmed LQTS (283 with LQT1, 193 with LQT2, and 52 with LQT3) were reviewed from which 2,618 electrocardiograms were analyzed over a median follow-up of 6.7 (interquartile range, 3.6 to 10 years) years. Eighty-two (15.5%; female 51%) patients were identified as having ERP; 40 (50%) of these ERP-positive patients showed persistent ERP. One hundred twenty-four patients (23.5%) were classified as previously symptomatic LQTS and 39 (7.2%) experienced a subsequent BCE. ERP was not associated with either symptomatic status (p = 0.62) or BCE (p = 0.61). Conclusions: Although ERP is common in LQTS, this extensive study suggests that the presence of concomitant ERP does not correlate with either those with a history of LQTS-triggered events prior to diagnosis or those with subsequent BCEs from their treated LQTS substrate.

AB - Objectives: This study sought to determine the prevalence of early repolarization pattern (ERP) within a large cohort of patients with long QT syndrome (LQTS) and examine the correlation and clinical significance of ERP with symptomatic status and subsequent risk of breakthrough cardiac events (BCEs). Background: The electrocardiographic ERP is associated with an increased risk of arrhythmic events and sudden cardiac death. Methods: ERP was defined as an end-QRS notch or slur on the downslope of a prominent R-wave with a J point ≥0.1 mV in 2 or more contiguous leads of the 12-lead electrocardiogram, excluding V1 to V3. A patient was considered previously symptomatic if they had a suspected LQTS-triggered cardiac event prior to diagnosis. BCEs were defined as LQTS-attributable syncope/seizures, aborted cardiac arrest, appropriate ventricular fibrillation–terminating implantable cardioverter-defibrillator shocks, and sudden cardiac death following diagnosis and institution of a LQTS-directed treatment program. Results: In this study, 528 patients (57% female) with genotype-confirmed LQTS (283 with LQT1, 193 with LQT2, and 52 with LQT3) were reviewed from which 2,618 electrocardiograms were analyzed over a median follow-up of 6.7 (interquartile range, 3.6 to 10 years) years. Eighty-two (15.5%; female 51%) patients were identified as having ERP; 40 (50%) of these ERP-positive patients showed persistent ERP. One hundred twenty-four patients (23.5%) were classified as previously symptomatic LQTS and 39 (7.2%) experienced a subsequent BCE. ERP was not associated with either symptomatic status (p = 0.62) or BCE (p = 0.61). Conclusions: Although ERP is common in LQTS, this extensive study suggests that the presence of concomitant ERP does not correlate with either those with a history of LQTS-triggered events prior to diagnosis or those with subsequent BCEs from their treated LQTS substrate.

KW - breakthrough cardiac events

KW - early repolarization

KW - electrophysiology

KW - long QT syndrome

UR - http://www.scopus.com/inward/record.url?scp=85052933988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052933988&partnerID=8YFLogxK

U2 - 10.1016/j.jacep.2018.06.007

DO - 10.1016/j.jacep.2018.06.007

M3 - Article

C2 - 30236400

AN - SCOPUS:85052933988

VL - 4

SP - 1238

EP - 1244

JO - JACC: Clinical Electrophysiology

JF - JACC: Clinical Electrophysiology

SN - 2405-5018

IS - 9

ER -